Terms ending in 2030
Every in-force patent on Biogen Ma Inc.'s record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,696,307 | Methods for the Detection of JC Polyoma Virus In force · Medium confidence | Biogen Ma Inc. | In force | Medium confidence | |
| US RE47,684 | Cytoprotective Agent In force · Low confidence | Corxel Pharmaceuticals Hong Kong Limited | In force | Low confidence | |
| US RE49,351 | Cytoprotective Agent In force (reinstated) · Low confidence | Corxel Pharmaceuticals Hong Kong Limited | In force (reinstated) | Low confidence | |
| US 8,568,586 | Automated System And Method For Monitoring Chromatography Column Performance, And Applications Thereof In force · High confidence | Biogen Ma Inc. | In force | High confidence | |
| US 9,533,044 | Methods of Treating Inflammatory Disorders Using High Concentration Natalizumab Compositions In force · Medium confidence | Biogen Ma Inc. | In force | Medium confidence | |
| US 11,111,307 | Anti-Bcma Antibodies In force · High confidence | Biogen Ma Inc. | In force | High confidence | |
| US D751,705 | Syringe In force · High confidence | Bioverativ Therapeutics Inc. | In force | High confidence | |
| US 8,647,625 | Anti-CD154 Antibodies In force · High confidence | Biogen Ma Inc. | In force | High confidence | |
| US 9,127,043 | Purification of Immunoglobulins In force · High confidence | Biogen Ma Inc. | In force | High confidence | |
| US 9,717,750 | Compositions and Methods for Modulation of SMN2 Splicing in a Subject In force · Medium confidence | Isis Pharmaceuticals, Inc. | In force | Medium confidence | |
| 18 more term ends in 2030 · Pro | |||||
10 of 28 patents shown. Soonest term end first, then patent number.
Pro members see all 28.
20 of these are in force and held by Biogen Ma Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.